m+Medelevator.RU
← Поиск публикаций
ACS applied materials & interfaces · 2025

A Strategy to Induce Calcium Ion Storm in Cancer Stem Cells for Efficient Cancer Therapy.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Chang Zhen, Wu Chunlan, Wu Xiayi, Liu Jun, Fu Rui, Lan Yuming, Liu Bing, Zou Shizun, Huang Jiacheng

Аннотация

Currently, tumor treatment strategies centered on Ca2+ homeostasis imbalance primarily target mature tumor cells while neglecting the eradication of cancer stem cells (CSCs), which results in the long-standing unresolved challenge of tumor relapse in later stages of treatment. To tackle the challenge, a calcium peroxide nanoparticle (CPN)-based strategy aimed at inducing an intracellular calcium ion storm in CSCs for efficient cancer therapy was proposed in this study. Typically, hyaluronic acid (HA)-stabilized hollow mesoporous calcium peroxide nanoparticles (HMCPN@HA4) were synthesized via a facile hydrolysis-precipitation method. Under an acidic tumor microenvironment (TME), 5(6)-carboxyeosin (CE)-loaded HMCPN@HA4 (HMCPN-CE3@HA4) degrades to release Ca2+, hydrogen peroxide (H2O2), and CE. CE impedes the cellular efflux of calcium ions, resulting in a state in which Ca2+ flows only into the cell and does not outflow (only in, not out), thereby inducing a calcium ion storm. These released components collectively promote ferroptosis and calcioptosis in tumor cells through Fenton reactions and Ca2+ storms, thereby effectively eliminating both CSCs and mature tumor cells. In vitro experimental results show that HMCPN-CE3@HA4 can significantly inhibit the stemness of MOC1 side population (SP) stem cells and produce significant toxicity, resulting in nearly 80% cell death. After intravenous administration, HMCPN-CE3@HA4 exhibits superior antitumor efficacy and excellent biosafety.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты